FI891004A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi

Info

Publication number
FI891004A0
FI891004A0 FI891004A FI891004A FI891004A0 FI 891004 A0 FI891004 A0 FI 891004A0 FI 891004 A FI891004 A FI 891004A FI 891004 A FI891004 A FI 891004A FI 891004 A0 FI891004 A0 FI 891004A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
pyrimidine derivatives
substituted pyrazolo
new therapeutically
Prior art date
Application number
FI891004A
Other languages
English (en)
Swedish (sv)
Other versions
FI92202B (fi
FI92202C (fi
FI891004A (fi
Inventor
Jeffrey B Press
Zoltan Hajos
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI891004A0 publication Critical patent/FI891004A0/fi
Publication of FI891004A publication Critical patent/FI891004A/fi
Priority to FI931574A priority Critical patent/FI931574A/fi
Publication of FI92202B publication Critical patent/FI92202B/fi
Application granted granted Critical
Publication of FI92202C publication Critical patent/FI92202C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI891004A 1988-03-03 1989-03-02 Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi FI92202C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI931574A FI931574A (fi) 1988-03-03 1993-04-07 4-substituerade pyrazolo/3,4-d/pyrimidinderivat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/163,488 US4885300A (en) 1988-03-03 1988-03-03 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives
US16348888 1988-03-03

Publications (4)

Publication Number Publication Date
FI891004A0 true FI891004A0 (fi) 1989-03-02
FI891004A FI891004A (fi) 1989-09-04
FI92202B FI92202B (fi) 1994-06-30
FI92202C FI92202C (fi) 1994-10-10

Family

ID=22590219

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891004A FI92202C (fi) 1988-03-03 1989-03-02 Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi

Country Status (15)

Country Link
US (3) US4885300A (fi)
EP (1) EP0331510A3 (fi)
JP (1) JP2567936B2 (fi)
KR (1) KR940002827B1 (fi)
CN (1) CN1030605C (fi)
AU (1) AU612797B2 (fi)
DK (1) DK101689A (fi)
FI (1) FI92202C (fi)
HU (1) HU204274B (fi)
IL (1) IL89459A (fi)
NO (1) NO169966C (fi)
NZ (1) NZ228168A (fi)
PH (1) PH25999A (fi)
PT (1) PT89904B (fi)
ZA (1) ZA891620B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712735A1 (de) * 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
EP0440515B1 (en) * 1990-01-30 1995-08-23 Visa International Service Association International authorization system
JP2651043B2 (ja) * 1990-07-10 1997-09-10 麒麟麦酒株式会社 ジフェニルメチルピペラジン誘導体
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
AU4219897A (en) * 1996-09-18 1998-04-14 Daiso Co. Ltd. Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
CA2263267C (en) * 1996-09-18 2006-05-02 Daiso Co., Ltd. Process for the preparation of glycidyl ethers
CN106070266B (zh) * 2016-06-29 2018-11-30 贵州大学 吡唑[3,4-d]嘧啶酮席夫碱类化合物在制备抗植物病毒剂中的应用
US10927084B2 (en) * 2017-01-26 2021-02-23 Tosoh Corporation Alkanolamine, friction-reducing agent, and lubricating oil composition
CA3068254A1 (en) 2017-06-20 2018-12-27 Imbria Pharmaceuticals, Inc. Compositions and methods for increasing efficiency of cardiac metabolism
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139705A (en) * 1977-05-20 1979-02-13 The Dow Chemical Company Pyrazolopyrimidines
FR2431710A1 (fr) * 1978-07-18 1980-02-15 Elf Aquitaine Procede d'exploration sismique par diagraphie acoustique
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4460303A (en) * 1982-07-29 1984-07-17 Ingersoll-Rand Company Drill pipe loader
US4603203A (en) * 1983-12-14 1986-07-29 Takeda Chemical Industries, Ltd. 3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
HU198052B (en) * 1986-02-14 1989-07-28 Sandoz Ag Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents

Also Published As

Publication number Publication date
FI92202B (fi) 1994-06-30
IL89459A (en) 1993-04-04
DK101689A (da) 1989-09-04
FI92202C (fi) 1994-10-10
IL89459A0 (en) 1989-09-10
CN1036766A (zh) 1989-11-01
JPH01279890A (ja) 1989-11-10
PH25999A (en) 1992-01-13
EP0331510A3 (en) 1991-03-13
DK101689D0 (da) 1989-03-02
PT89904A (pt) 1989-11-10
EP0331510A2 (en) 1989-09-06
NO169966B (no) 1992-05-18
US4885300A (en) 1989-12-05
ZA891620B (en) 1990-11-28
KR940002827B1 (ko) 1994-04-04
KR890014542A (ko) 1989-10-24
FI891004A (fi) 1989-09-04
NO890894D0 (no) 1989-03-02
NO169966C (no) 1992-08-26
NZ228168A (en) 1991-07-26
AU612797B2 (en) 1991-07-18
US5001127A (en) 1991-03-19
AU3088389A (en) 1989-09-07
USRE35072E (en) 1995-10-24
NO890894L (no) 1989-09-04
CN1030605C (zh) 1996-01-03
HUT49353A (en) 1989-09-28
HU204274B (en) 1991-12-30
JP2567936B2 (ja) 1996-12-25
PT89904B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
NO954490L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive pyrimidinforbindelser
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO173442C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
FI95570C (fi) Menetelmä lääkinnällisesti vaikuttavien pyridatsinoni-3(2H)-onijohdannaisten valmistamiseksi
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
FI890028A0 (fi) Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi
FI891339A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
FI891004A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
DK584288A (da) Fremgangsmaade til fremstilling af guaninderivater
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI910448A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
FI912247A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
HU896030D0 (en) Process for the preparation of quinazolinone derivatives
FI901094A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten triatsolopyrimidiinijohdannaisten valmistamiseksi
FI954169A0 (fi) Menetelmä 3-substituoitujen 2-oksoindolijohdannaisten valmistamiseksi
LV5266A3 (lv) Panemiens 1,3-aizvietoto tetrahidro-1h-tieno-(3,4-d)-imidazol-2-(3h)-on-4-4-iliden-pentanskabju esteru iegusanai
NO178304C (no) Mellomprodukt for fremstilling av pyrrolopyrimidinderivater

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: ORTHO PHARMACEUTICAL CORPORATION